Overall survival (OS) with CPX-351 versus 7+3 in older adults with newly diagnosed, therapy-related acute myeloid leukemia (tAML): Subgroup analysis of a phase III study.

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Lancet, JE; Rizzieri, D; Schiller, GJ; Stuart, RK; Kolitz, JE; Solomon, SR; Newell, LF; Erba, HP; Uy, GL; Ryan, R; Chiarella, M; Louie, AC; Cortes, JE

Published Date

  • May 20, 2017

Published In

Volume / Issue

  • 35 / 15_suppl

Start / End Page

  • 7035 - 7035

Published By

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/jco.2017.35.15_suppl.7035